CORDIS
EU research results

CORDIS

English EN
Training in Extracellular Vesicles: for benefit in Health and Disease

Training in Extracellular Vesicles: for benefit in Health and Disease

Objective

Exosomes and microvesicles/ectosomes, collectively termed extracellular vesicles (EV), have attracted much recent interest because of their potential functions, use as disease biomarkers and possible therapeutic exploitation. Due to their enormous relevance, this relatively new field of research is quickly expanding. While Europe leads the field of EV research, there are still many gaps in knowledge that need to be addressed to ensure optimal exploitation of EVs from health and Europe’s economic benefit. Addressing this, TRAIN-EV’s objective is to provide excellent and integrated multi-disciplinary and inter-sectoral training of a critical mass of ESRs of outstanding potential in the academic, clinical, and industry/business components of exploiting EV, while performing novel cutting-edge research to address these gaps and generate new knowledge. This will be achieved by appointing 15 ESRs into 10 Beneficiary Organisations (6 academic; 4 non-academic), with 4 additional Partner Organisations (3 non-academic; 1 academic) offering secondments, training and additional networking opportunities. All Participants have highly relevant and complementary medical/science/engineering/business expertise –detailed within– that will collectively contribute to the training, to PhD level, of these 15 ESRs as academic and industry EV leaders for the future.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN

Address

College Green
2 Dublin

Ireland

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 531 349,20

Participants (9)

Sort alphabetically

Sort by EU Contribution

Expand all

INSTITUT CURIE

France

EU Contribution

€ 489 039,56

SEMMELWEIS EGYETEM

Hungary

EU Contribution

€ 447 827,04

UNIVERSITAETSKLINIKUM FREIBURG

Germany

EU Contribution

€ 498 432,96

UNIVERSITEIT UTRECHT

Netherlands

EU Contribution

€ 510 748,56

HANSABIOMED LIFE SCIENCES OU

Estonia

EU Contribution

€ 226 264,68

BIOINF2BIO LDA

Portugal

EU Contribution

€ 238 356,36

GVS S.P.A.

Italy

EU Contribution

€ 258 061,32

AJ INNUSCREEN GMBH

Germany

EU Contribution

€ 23 052,52

UNIVERSITEIT GENT

Belgium

EU Contribution

€ 501 120

Project information

Grant agreement ID: 722148

Status

Ongoing project

  • Start date

    1 October 2017

  • End date

    30 September 2021

Funded under:

H2020-EU.1.3.1.

  • Overall budget:

    € 3 724 252,54

  • EU contribution

    € 3 724 252,20

Coordinated by:

THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN

Ireland